1. Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer

   • Katherine K. Bass
   • Michael J. Mastrangelo

   REVIEW Pages: 1 - 12

2. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres

   • Jie Ma
   • John Samuel
   • Ragupathy Madiyalakan

   ORIGINAL ARTICLE Pages: 13 - 20

3. Induction of HLA-unrestricted and HLA-class-II-restricted cytotoxic T lymphocytes against MUC-1 from patients with colorectal carcinomas using recombinant MUC-1 vaccinia virus

   • Junji Akagi
   • Kazuhiro Nakagawa
   • Michio Ogawa

   ORIGINAL ARTICLE Pages: 21 - 31

4. Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells

   • Kun Li
   • Medi Adibzadeh
   • Graham Pawelec

   ORIGINAL ARTICLE Pages: 32 - 38

5. Biodistribution of ¹¹¹In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01

   • Helma M. Prinssen
   • Carla F. M. Molthoff
   • Alan C. Perkins

   ORIGINAL ARTICLE Pages: 39 - 46

6. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells

   • Megumi Miyamoto
   • Yukihiro Shimizu
   • Akiharu Watanabe

   ORIGINAL ARTICLE Pages: 47 - 57

7. Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma

   • Nitya G. Chakraborty
   • Jonathan R. Sporn
   • Bijay Mukherji

   ORIGINAL ARTICLE Pages: 58 - 64